A detailed history of Fcpm Iii Services B.V. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 5,954,069 shares of DYN stock, worth $142 Million. This represents 36.73% of its overall portfolio holdings.

Number of Shares
5,954,069
Previous 7,845,364 24.11%
Holding current value
$142 Million
Previous $277 Billion 22.75%
% of portfolio
36.73%
Previous 40.83%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$31.94 - $47.04 $60.4 Million - $89 Million
-1,891,295 Reduced 24.11%
5,954,069 $214 Billion
Q1 2024

May 03, 2024

BUY
$13.06 - $29.18 $22.4 Million - $50 Million
1,714,285 Added 27.96%
7,845,364 $223 Billion
Q4 2023

Mar 07, 2024

BUY
$6.62 - $13.64 $40.6 Million - $83.6 Million
6,131,079 New
6,131,079 $81.5 Billion

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Fcpm Iii Services B.V. Portfolio

Follow Fcpm Iii Services B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcpm Iii Services B.V., based on Form 13F filings with the SEC.

News

Stay updated on Fcpm Iii Services B.V. with notifications on news.